Literature DB >> 24817342

CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance: response.

Gabriel Cara-Fuentes1, Richard J Johnson, Jochen Reiser, Eduardo H Garin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24817342      PMCID： PMC4136515          DOI： 10.1007/s00467-014-2840-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  4 in total

1.  Abatacept in B7-1-positive proteinuric kidney disease.

Authors:  Chih-Chuan Yu; Alessia Fornoni; Astrid Weins; Samy Hakroush; Dony Maiguel; Junichiro Sageshima; Linda Chen; Gaetano Ciancio; Mohd Hafeez Faridi; Daniel Behr; Kirk N Campbell; Jer-Ming Chang; Hung-Chun Chen; Jun Oh; Christian Faul; M Amin Arnaout; Paolo Fiorina; Vineet Gupta; Anna Greka; George W Burke; Peter Mundel
Journal:  N Engl J Med       Date:  2013-11-08       Impact factor: 91.245

2.  [Diagnostic value of soluble urokinase-type plasminogen activator receptor serum levels in adults with idiopathic nephrotic syndrome].

Authors:  Alfons Segarra; Elías Jatem; M Teresa Quiles; M Antonia Arbós; Helena Ostos; Naiara Valtierra; Clara Carnicer; Irene Agraz; M Teresa Salcedo
Journal:  Nefrologia       Date:  2014       Impact factor: 2.033

3.  Urinary CD80 excretion increases in idiopathic minimal-change disease.

Authors:  Eduardo H Garin; Leila N Diaz; Wei Mu; Clive Wasserfall; Carlos Araya; Mark Segal; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

4.  CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.

Authors:  Gabriel Cara-Fuentes; Changli Wei; Alfons Segarra; Takuji Ishimoto; Christopher Rivard; Richard J Johnson; Jochen Reiser; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2013-11-22       Impact factor: 3.714
  4 in total
  2 in total

1.  Urinary CD80: a biomarker for a favorable response to corticosteroids in minimal change disease.

Authors:  Gabriel Cara-Fuentes; Miguel A Lanaspa; Gabriela E Garcia; Mindy Banks; Eduardo H Garin; Richard J Johnson
Journal:  Pediatr Nephrol       Date:  2018-03-01       Impact factor: 3.714

2.  Multidimensional inflammatory and immunological endotypes of idiopathic focal segmental glomerulosclerosis and their association with treatment outcomes.

Authors:  Neus Roca; Alvaro Madrid; Mercedes Lopez; Gloria Fraga; Elias Jatem; Jorge Gonzalez; Cristina Martinez; Alfons Segarra
Journal:  Clin Kidney J       Date:  2020-12-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.